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We have solved the structure of ferredoxin-NADP(H) reductase, FPR, from the plant pathogen Xanthomonas axonopodis pv. citri,
responsible for citrus canker, at a resolution of 1.5 A˚. This structure reveals differences in the mobility of specific loops when
compared to other FPRs, probably unrelated to the hydride transfer process, which contributes to explaining the structural and
functional divergence between the subclass I FPRs. Interactions of the C-terminus of the enzyme with the phosphoadenosine of the
cofactor FAD limit its mobility, thus affecting the entrance of nicotinamide into the active site. This structure opens the possibility
of rationally designing drugs against the X. axonopodis pv. citri phytopathogen.
1. Introduction
Ferredoxin-NADP(H) reductases (FNRs, EC 1.18.1.2) con-
stitute a family of hydrophilic FAD-containing monomeric
enzymes that deliver NADPH or low potential one-electron
donors to redox-based metabolisms in plastids, mitochon-
dria, and bacteria [1]. In heterotrophic bacteria, this activity
provides reduced ferredoxin and flavodoxin to diverse reac-
tions involved in amino acid and nucleotide metabolisms,
biotin synthesis, and iron-sulphur cluster assembly, as well
as for the nitrogenase complex [1]. Based on phylogenetic
analysis, the FNR forms present in most prokaryotes (collec-
tively known as FPRs) have been classified into two subclasses
represented by theAzotobacter vinelandii (subclass I) and the
Escherichia coli (subclass II) FPR prototypes [1]. Structures of
bacterial FPRs, as well as those of plastidic FNRs, are folded
in two distinct domains: the C-terminus with a binding
site for NADP(H) and the N-terminus binding the cofactor
FAD. Unlike plastidic enzymes, bacterial ones show a bent
conformation of FAD. This conformation is stabilised by an
intramolecular H-bond between the N6 atom of the adeno-
sine and the N1 atom of the isoalloxazine rings, and by
stacking of an aromatic side chain against the carboxy-
terminal extension and the adenosine moiety. The very low
turnover rates for the oxidation of NADPH exhibited by
bacterial FPRs in comparison with plastidic enzymes may
be associated with this FAD folded conformation, unlike the
extended conformation in plastidic FNRs [2] (see Table S1
in Supplementry Material available online http://dx.doi.org/
10.1155/2013/906572).
Xanthomonas axonopodis pv. citri is a gram-negative
bacterium responsible for citrus canker, a severe disease that
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affects most commercial citrus crops. Bacteria penetrate host
plant tissues through stomata and wounds and colonize the
apoplast causing cell hyperplasia. Symptoms are ultimately
visualized as necrotic corky lesions on leaves, stems, and fruit
surfaces. This disease has an important economic impact
worldwide, due to reduction of fruit quality, premature
abscission of fruits and leaves, and general tree decline [3].
The genome of X. axonopodis pv. citri contains the fpr gene
that encodes the FPR (XacFPR). Despite the fact that neither
the role of XacFPR nor its potential substrate has been
elucidated, its involvement in the oxidative stress response
of X. axonopodis pv. citri via interaction with ferredoxin
XAC1762 has been proposed [4]. Therefore, XacFPR appears
to be a key enzyme for pathogen survival, and the inhibition
of its activity might represent an effective treatment against
citrus canker caused by X. axonopodis pv. citri.
XacFPRpossesses characteristic features of subclass I bac-
terial reductases, but its functional characterization revealed
differences in the isoalloxazine environment related to
the subclass I bacterial FPR from Rhodobacter capsulatus
(RcFPR) [4]. Such differences may be associated with their
distinct C-terminal regions, where the RcFPR has two addi-
tional residues (Figure S1). Thus, based on differences in the
primary sequences in the C-terminal domains, a subdivision
of subclass I bacterial FPRs into IA and IB has been proposed
[4]. We here report the crystal structure of XacFPR at a reso-
lution of 1.5 A˚. Even though XacFPR adopts many structural
characteristics of this bacterial subclass [4], loops distributed
in the two domains show different mobility in terms of B
factor values among FPRs from subclass IA and IB. Subclass
IA FPRs, to which XacFPR belongs, are characterised by the
short C-terminal sequence VEK (Figure S1). The C-termi-
nal glutamic residue side chain (Glu258, numbering as in
XacFPR) establishes an interaction with the O2󸀠 of the FAD
ribityl in the XacFPR and Pseudomonas aeruginosa FPR
(PaFPR) structures, but not in that of A. vinelandii FPR
(AvFPR). Finally, in XacFPR, the exposure of FAD to the sol-
vent is limited by interaction of the phosphoadenosine phos-
phate moiety of the cofactor with the side chain of Lys259,
probably introducing structural restrictions to the enzyme
catalytic turnover.
2. Materials and Methods
2.1. Protein Expression and Purification. XacFPR was cloned
and purified as previously reported [4]. Briefly, the coding
sequence for XacFPR, amplified by PCR, was introduced
into pET28a vector between NdeI and EcoRI sites. The
resulting 6His.tag-FPR fusion protein was purified using Ni-
NTA chromatography, and, after thrombin treatment, a sec-
ond affinity Ni-NTA chromatography separates the 6His.tag
extension from the XacFPR protein. Crystallization trials
of XacFPR demanded an additional purification step that
consisted of a molecular exclusion chromatography using a
Sephacryl S-200 column from GE Healthcare. The protein
was obtained in 50mM Tris-HCl pH 8.0, 150mM NaCl and
concentrated up to 20mg/mL. For protein concentration
calculation by absorbance spectra, a value of 10.7mM−1 cm−1
for the extinction coefficient at 450 nm was used.
2.2. Crystallization and Data Collection. Crystals of the
XacFPR were obtained using the hanging drop vapour dif-
fusion method at 292K. A typical drop contained 2 𝜇L of
20mg/mL protein solution buffered with 50mM Tris-HCl
pH 8.0, 150mM NaCl, and 4 𝜇L of reservoir solution con-
taining 4.3M NaCl and 100mMHepes pH 7.5. Droplets were
equilibrated against 0.5mL of reservoir solution. Crystals
reached their maximum size in one week and were soaked
in a cryoprotectant solution containing 75% of mother liquor
and 25% of glycerol. Data were collected from a single crystal
of XacFPR using the synchrotron source ESRF beamline
BM16 and anADSCQuantum 210 detector with a wavelength
of 0.99 A˚, to a maximum resolution of 1.5 A˚. The crystal
belonged to the I222 orthorhombic space group with unit cell
dimensions shown in Table 1. The calculated Matthews coef-
ficient and the solvent content were 2.58 A˚3/Da and 52.3%,
respectively, corresponding to one molecule in the asymmet-
ric unit. The data were processed and scaled using XDS [5]
and SCALA [6] from the CCP4 package [7]. The structure
was solved by molecular replacement using the program
MOLREP from CCP4 and the structure of RcFPR (PDB code
2BGJ) as the search model. The first model of the XacFPR
was automatically built with ARP/wARP [8]. Refinement was
performed by REFMAC [9] from the CCP4 package, using
the restrained refinement with atomic isotropic B factor and
alternating manual model building by COOT [10]. The final
model included residues 4–259, one FAD molecule, one Cl−
ion, and solventmolecules. Stereochemistry of themodel was
checkedwith PROCHECK [11].MOLPROBITY [12]was used
to assess the quality of the final structure. Two residues (T47
and E165) are in outliers region of Ramachandran plot, the
electron density map around them being not good enough
to position them precisely. Relevant data collection statistics
and refinement parameters are presented in Table 1.The coor-
dinates and structure factors forXacFPR have been deposited
in the Protein Data Bank with accession code 4B4D.
3. Results and Discussion
3.1. Overall Structure. The overall structure of XacFPR
strongly resembles those of bacterial FPRs from subclass I.
It is organised in the two typical domains present in the
ferredoxin-NADP(H) reductase family (Figure 1(a)). The N-
terminus (residues 4–98) folds into a six-stranded antiparallel
𝛽-barrel (𝛽1–𝛽6) capped by helix 𝛼1. FAD binds to this
domain, near the N-terminal end of 𝛼1 and the carboxy ends
of the strands 𝛽4 and 𝛽5. The C-terminus (residues 99–259)
adopts a classical nucleotide binding fold with a five-stranded
parallel 𝛽-sheet surrounded by nine 𝛼-helices. The interface
between both domains is formed by helix 𝛼3 of the C-domain
and residues from loops connecting 𝛽2 with 𝛽3 and 𝛽4 with
𝛽5 at the N-domain. Finally, a chloride ion coming from
the crystallization mother liquor is located between helices
𝛼8 and 𝛼10, at the C-domain, stabilised by the OG1 atom of
Thr193 and two water molecules.
3.2. FAD Binding Site. Figure 1(b) shows the folded confor-
mation and local environment of FAD in XacFPR. As in all
known bacterial FPR structures, the cofactor adopts a bent
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Figure 1: (a) Cartoon representation of XacFPR structure. The N-domain is shown in yellow and the C-domain in green. The unbiased
(before inclusion of FAD) |𝐹o| − |𝐹c|, 𝐹calc electron density map is shown at 2.2 𝜎. FAD is in sticks with carbons in grey. Chloride ion is a red
sphere. (b) Stereo representation of the FAD environment. Carbon atoms of amino acid residues and FAD are shown in white and orange,
respectively. H-bonds involved in FAD stabilization are represented as dotted lines. (c) Cartoon superimposition of the active site of XacFPR
(in grey), PaFPR:NADP+ complex (pdb 3crz, in orange), and RcFPR:NADP+ complex (pdb 2vnj, in green). FAD, in sticks and with carbons
in grey, belongs to XacFPR structure and occupies similar position to FADs of Pa and RcFPRs complexes. NADP+s from complexes are in
sticks. C-terminuses of the three structures are pointed to by arrows.
conformation that differs from the extended one in plastidic
FNRs, placing the adenine and isoalloxazine rings in close
proximity. The main driving force maintaining this bent
conformation appears to be provided by the stacking of
the adenine ring against the Phe256 and Ile70 side chains,
while additional electrostatic and hydrophobic interactions
contribute to stabilizing the overall binding. The O4 and
O2 atoms of the FAD isoalloxazine ring interact with the
amides of Ser55 and Ile70, respectively, while the N3 and N10
positions are stabilised by the backbone O atoms of Phe68,
Ala53, and Ala255. The conserved Tyr54 is stacked in the
si-face of FAD. Finally, the two C-terminal residues, Glu258
and Lys259, stabilise the position of the ribityl moiety of the
cofactor through polar interactions, while the side chain of
Lys259 establishes a salt bridge interaction with one of the
phosphates of FAD (as reported for homologous Lys ofPaFPR
and AvFPR).
Based on the overall structure and FAD binding site
organisation, XacFPR seems to share many structural char-
acteristics of other known bacterial FPRs.
3.3. Comparison with Other Bacterial Subclass I FPRs. The
crystal structure is quite similar to those of other subclass IA
FPRs, PaFPR, and AvFPR. Superposition of those structures
onto that of XacFPR shows r.m.s.d. values ∼0.63 A˚ (for 227
and 237 C𝛼 atoms aligned, resp.) (Figure 2(a)), consistent
with the high identity in structure-based sequence alignment
(identity of 41.7% and 41%, resp.) (Figure S1). The third
known structure of subclass I bacterial FPR,RcFPRbelonging
to subclass IB, shows a slight higher r.m.s.d. value, 0.80 A˚,
when superposed to XacFPR. The mayor overall difference
among all these structures is in the conformation adopted
for some residues in helices 𝛼6 and 𝛼7 and for the loop
connecting them (residues 158–173, XacFPR numbering)
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Figure 2: (a) Stereo cartoon representation of the 𝛼-carbon B-fac-
tors alignment forXacFPR (green),AvFPR (pink), PaFPR (blue) and
RcFPR (yellow) by Pymol. Positions with larger fluctuations are
indicated in wide cartoonwhile those with the lower fluctuations are
shown as thin cartoon. FAD from XacFPR is displayed in space
filling with carbons in green. Inset; detail of C-terminal homologous
residues of FPRs from subclass IA in sticks. Interactions between
Glu258 and FAD inXacFPR are shown as dashed lines.The FAD and
the side-chain of Glu258 are in space filling and sticks, respectively,
and bothCPK coloured. (b)Detail of the different exposition of FAD
in XacFPR (blue) and RcFPR (dark yellow) due to the conformation
of side chains of Lys259 andGlu270, respectively. Red balls represent
water molecules and respective polar contacts of Lys259 and Glu270
with their environment are shown in dashed lines.
(Figure 2(a)). This region shows the highest B factor values
in the RcFPR and XacFPR structures and, therefore, seems
to present high flexibility in these FPRs (Figure 2(b)). This
portion of the enzyme is situated in the protein surface
opposite to the FAD binding site and also far away from the
putative NADPH/NADP+ binding site.
Two other long loops also differ in conformation with
respect to the other subclass I FPRs: loop 44–49 that connects
𝛽3 with 𝛽4 and loop 241–248 located between 𝛼10 and 𝛽11.
This latter loop, 241–248, exhibits low B factor values in
XacFPR, while they are relatively high in RcFPR structure
and moderate in AvFPR and PaFPR. All those areas are well
exposed to the solvent. It is not clear whether such differences
Table 1: Data collection and structural refinement statistics of
XacFPR.
Data collection statistics
Space group I222
Cell dimensions a, b, c (A˚) 50.70, 99.78, 118.79
Wavelength, A˚ 0.99994
Resolution, A˚ 24.06–1.50 (1.58–1.50)
Total number of reflections 215020
Number of unique reflections 46901 (5597)
Redundancy 4.6 (2.9)
Completeness, % 96.7 (79.8)
Average 𝐼/𝜎 13.7 (1.9)
𝑅merge
a 0.057 (0.607)
Refinement statistics
Resolution range, A˚ 24.06–1.50
Protein nonhydrogen atoms 2072
Ligand nonhydrogen atoms 54
Solvent nonhydrogen atoms 238
𝑅work
b (%) 20.6
𝑅free
b (%) 22.7
r.m.s.d. bond length, A˚ 0.007
r.m.s.d. bond angles, ∘ 1.316
Average B factor, A˚2
All 21.60
Protein 20.98
Ligands: FAD
Cl−
14.25
24.28
Waters 28.59
Ramachandran statistics
Res. in preferred regions (%) 97.64
Res. in allowed regions (%) 1.57
Res. outliers (%) 0.79
Values in parentheses correspond to the highest resolution shell.
a
𝑅sym = ∑ |𝐼 − 𝐼av|/ ∑ 𝐼, where the summation is over symmetry equivalent
reflections.
b
𝑅work and 𝑅freewere calculated by the equation ∑ ||𝐹obs| − |𝐹calc||/ ∑ |𝐹obs|,
where𝐹obs and𝐹calc are the observed and calculated structure factors, respec-
tively. 𝑅free was calculated for 7% of data excluded from the refinement.
are related to the reactivity towards the NAPDH coenzyme or
to the interactions with their protein partners.
The conformation of the last seven C-terminal residues of
XacFPR is identical to that of the equivalent residues PaFPR
and AvFPR, with the exception of the side chain of Glu258
(numbering XacFPR) (Figure 2(a) inset). In XacFPR struc-
ture, this residue adopts the same conformation as Glu257 in
PaFPR, pointing its OE1 side chain to the O2 ribityl of the
FAD. In contrast, in AvFPR the corresponding amino acid
is not engaged in such interaction and appears exposed to
the solvent. The interaction of the C-terminal Lys259 with
the phosphate of the FAD is conserved in PaFPR and AvFPR
(Figure 1(b)). This Lys residue is well conserved among all
FPRs from subclass IA with the exception ofNeisseria menin-
gitidis (UniProt NMB1044) and Xylella fastidiosa (UniProt
Q3R3Y4), where a Gln might play the Lys role. As a con-
sequence of this interaction a decrease in mobility of the
adenosine of FAD might be expected in subclass IA FPRs.
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The C-terminal extension in subclass I FPRs appears to
be a mechanism to protect the expected stacking between the
nicotinamide ring of the incoming hydride donor, NADPH,
and the isoalloxazine of FAD, an interaction required for
hydride transfer during catalysis. Therefore, a relatively large
conformational rearrangement should take place in this
region to achieve a catalytically competent interaction. All
the FPR:NADP+ complexes for which structures have been so
far solved show an apparent unproductive coenzyme binding
(2vnh, 2vnj, 2vnk, 3crz) (Figure 1(c)). In the subclass IB
RcFPR:NADP+ complex, the nicotinamide hydride donor
protrudes towards the solvent, far from producing a compe-
tent structure for hydride transfer [13]. The C-terminal end
of the protein prevents the nicotinamide from entering into
the active site, since the flavin re-face is closed by Ile272
and Arg158. Nevertheless, in the subclass IA PaFPR:NADP+
complex [14] the shorter C-terminus apparently allows the
nicotinamide to adopt a conformation that might precede
the productive one (Figure 1(c)). This structural context in
subclasses IA and IB FPRs could help to explain whyXacFPR,
with the same conformation in its C-terminal residues as
PaFPR, exhibits higher catalytic efficiency in the NADPH-
diaphorase activity than RcFPR [4, 13] (Table S1). Moreover,
while in the RcFPR structure the side chain of Glu270 is ori-
entated outwards of the structure, in XacFPR, as mentioned
previously, the homologous residue Lys259 binds the phos-
phate of FADwith its side chain (Figure 2(b)).This structural
difference at C-terminus means a different exposure of the
cofactor in both FPRs that might further contribute to
explaining the different kinetic behaviours (Table S1).
The structural information also allows postulating that
in bacterial FPRs opening of the catalytic site for productive
nicotinamide binding and allocation in the active site might
take place through the interaction between the carboxylate
groups of C-terminal residues (Lys259 in XacFPR and Ile272
in RcFPR) or the protein backbone and the nicotinamide
of NADPH. Molecular dynamics simulations [15] recently
identified the importance of the Tyr side chain of the C-
terminal residue in plastidic FNRs (Y303 in Anabaena FNR)
to obtain the optimum geometry for the hydride transfer
process. In subclass I bacterial FPRs no equivalent residue
to this plastidic Tyr is present, but the protein core formed
by residues Ala255-Phe256-Val257 and the adenine moiety
of the FAD in bent conformation might contribute in a
similar manner. In that case, allocation of the nicotinamide
in the active site in bacterial FPRs might require additional
conformational changes of that region regarding the plastidic
enzymes to obtain the catalytically competent complex. This
could further contribute to explaining the low efficiency of
this FPR as reductase as compared with plastidic enzymes.
4. Conclusions
Here we describe the first crystal structure of XacFPR. This
structure shows structural features that correspond to a pro-
tein from bacterial subclass IA but with detectable differences
in the mobility of specific loops when compared with other
known bacterial FPRs. Interactions involving the C-terminal
Glu-Lys residues of XacFPR with FAD are suggested to limit
cofactor mobility, which might be a key point in defining the
catalytic behaviour of the enzyme. Since XacFPR is essential
for X. axonopodis pv. citri survival, this structure constitutes
a starting point in the development of drugs against citrus
canker.
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